Home / Inspections / 1140938

FDA Inspection 1140938 — Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation — FEI 1627241

The FDA completed an inspection of Biotest Pharmaceuticals Corporation on March 17, 2021 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 17, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)

Facility

Other inspections at this facility

  • 1028318 (NAI Fri Aug 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 907096 (NAI Fri Dec 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 788428 (NAI Thu Jun 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 634629 (NAI Wed Dec 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources